Universitat Jaume I
Castellon, 12071, Spain
NCT Number: NCT03990259
This study has as main objective to asses different genetic, biochemical and physiological biomarkers affecting performance and health status in ultraendurance runners according to individual's sex.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Castellon, 12071, Spain
Ultraendurance races has been shown to impact on several health-related biomarkers, and therefore they may have detrimental effects on runners' health. In this study, we aim to analyze the impact of running a 107,6 km mountain race in ultraendurance runners splitting our sample by individual's sex.
To do this, baseline measurements of the runners have been collected through stress tests and biochemical analyses of blood and urine samples. Indeed, a saliva sample was collected to isolated a genomic DNA sample of each runner.
During the race anthropometrical, ventilatory and strength data was collected in three different moments and after crossing the finish line. Indeed, after completed the ultraendurance mountain race, blood and urine samples were taken at the finish line, as well as 24h and 48h post-race.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The runners completed a 107,6 km mountain race
Time frame: 12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the race
Blood concentration of estradiol, testosterone, progesterone, creatinine, troponin, C-reactive protein, hemoglobin, sodium, potassium, chlorine, iron, and ferritin. Concentration of all these parameters is expressed in mass per volume (i.e. nanograms per milliliter)
Time frame: 12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the race
Blood concentration of lactate dehydrogenase and creatine kinase. The enzyme concentration is expressed in units per volume (enzyme units per milliliter)
Time frame: 12 hours before the race, 15 minutes after the race, 24 hours after the race and 48 hours after the race
Blood concentration of erythrocytes, hematocrit, leukocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils, and platelet volume. The concentration of each cell type is expressed in number of cells per volume (cells per liter)
Time frame: 12 hours before the race, 15 minutes after the race
Squat Jump (high of the jump measured in centimeters)
Time frame: 12 hours before the race, and 15 minutes after the race
Pulmonary function test by spirometry. The parameters measured are vital capacity (VC), forced vital capacity (FVC), maximal mid-expiratory flow (MEF) and total lung capacity. Outcome data of all these parameters are expressed in liters.
Time frame: 12 hours before the race, and 15 minutes after the race
Pulmonary function test by spirometry. The parameters measured are forced expiratory volume in 1 second (FEV1) and in 6 seconds (FEV6) and peak expiratory flow (PEF). Outcome data of all these parameters are expressed in liters per second.
Time frame: 12 hours before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the race
Hand grip (pressure in kilograms)
Time frame: 60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the race
Ventilatory Flow measurement (liters per minute)
Time frame: 60 minutes before the race and 15 minutes after the race
Urine test to measure the concentration of sodium and creatinine, as well as urine density
Time frame: From 9 hours before starting the race to 48 hours after crossing the finish line.
Physical activity measured by wearing accelerometer devices. Physical activity defined as sedentary, light, moderate, vigorous, very vigorous and extremely vigorous. The aim to wear accelerometers devices is to monitor individuals.
Time frame: 12 hours before the race
Analysis of different polymorphisms in genomic DNA samples, which were isolated from the saliva sample of each participant.
Time frame: 12 hours before the race
Analysis of the telomere length in genomic DNA samples, which were isolated from saliva samples of each participant
Time frame: One month before the race day
Personal questionnaire asking for social status. Multiple-choice questions. Participants choose one of the different possible answers. Data is encoded as a factor variable with different levels.
Time frame: One month before the race day
Personal questionnaire asking for training habits. Multiple-choice questions. Participants choose one of the different possible answers. Data is encoded as a factor variable with different levels.
Time frame: One month before the race day
Personal questionnaire asking for training habits. Open-ended questions. Females answer questions regarding menstrual cycle (duration, dates, regularity, quantity of bleeding, pregnancy history, dysmenorrhea).
Time frame: One month before the race day
Maximal oxygen consumption (milliliters of oxygen used in one minute per kilogram of body weight)
Time frame: 12 hours before the race, and 15 minutes after the race,
Bioimpedance analysis (percentage of body fat, fat-free mass and water)
Time frame: Through race completion (the time that a runner is performing the 107 kilometers of the race, an average of 25 hours)
Recording the number of contractions of the heart per minute (bpm) by using a heart rate monitor during the race
Time frame: 60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the race
Borg ratings of perceived exertion (CR10). Scale with ten levels (0-Nothing at all, and 10-Extremely)
Time frame: 12 hours before the race, 15 minutes after the race, and 48 hours after the race
Evaluation of perceived muscle damage in a 10-level scale. Scale with ten levels (0-Nothing at all, and 10-Extremely)
Time frame: 60 minutes before the race, in three moments during the race (after running 33km, 65km and 94 km), and 15 minutes after the race,
Body mass measurement (weight in kilograms)
Universitat Jaume I
Other
Acronym: PTSW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05389111
Physical Exertion
Grenoble, France
View Trial DetailsNCT07046598
Body Mass Index, Creatine Kinase
Serdivan, Sakarya, Turkey (Türkiye)
View Trial DetailsNCT05462977
Affect, Alzheimer Disease
Greensboro, North Carolina, United States
View Trial DetailsNCT05820399
Desire to Exercise, Exercise Training
Iowa City, Iowa, United States
View Trial Details